News
IGM Financial Inc. ( TSE:IGM ) has announced that it will pay a dividend of CA$0.5625 per share on the 31st of ...
9h
Zacks Investment Research on MSNIGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue EstimatesIGM Biosciences, Inc. (IGMS) came out with a quarterly loss of $0.86 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to loss of $0.83 per share a year ago. These ...
Sales started to slow in the spring, as market uncertainty began to weigh on investor confidence, says CEO James O’Sullivan ...
After losing its powerhouse partner, IGM Biosciences closed “most” of its labs and offices and initiated a strategic review ...
Sanofi has scrapped its collaboration with IGM Biosciences, eliminating the biotech’s l | Sanofi has scrapped its ...
2d
News Medical on MSNSniffing Out the Flu: How a Supercharged Nasal Antibody Shields Against Viral AmbushScientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.
Power Corporation of Canada (Power Corporation or the Corporation) (TSX: POW) (TSX: POW.PR.E) today reported earnings results for the three months ended March 31, 2025.
US biotech IGM Biosciences (Nasdaq: IGMS), which is developing and delivering medicines to treat patients with autoimmune and ...
IGM Financial Inc. reported adjusted net earnings of $237.8 million for the first quarter, up 5.9% from the same quarter of ...
Detailed price information for Igm Financial Inc (IGM-T) from The Globe and Mail including charting and trades.
Thank you for standing by. This is the conference operator. Welcome to the IGM Financial First Quarter 2025 Analyst Call and Webcast. As a reminder, all participants are in a listen-only mode and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results